Login / Signup

The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms.

Sigbjørn BerentsenJosephine M I VosAgnieszka MaleckaGeir E TjønnfjordShirley D'Sa
Published in: Expert review of hematology (2024)
The patient's individual clinical profile regarding complement involvement and hemolytic versus non-hemolytic features is important for the choice of treatment. Further development of treatment approaches is encouraged, and some candidate drugs are promising irrespective of clinical phenotype. Patients with CAD requiring therapy should be considered for inclusion in clinical trials.
Keyphrases
  • clinical trial
  • coronary artery disease
  • randomized controlled trial
  • depressive symptoms
  • sleep quality
  • study protocol
  • cell therapy
  • open label
  • decision making